Company / strategic investorRegistered location :Allschwil, CHGroup :Idorsia Pharmaceuticals Ltd

Idorsia LtdDeclared Swiss shareholdings

Idorsia Ltd: 2 Swiss companies with a declared holding, including Idorsia Ltd, Santhera Pharmaceuticals Holding AG. Latest filing: 19.08.2026.

Disclosure tracking · company alerts with Pro
Estimated value (CHF)
…
Swiss companies held
2
Largest position
18,28 %
Idorsia Ltd
12-month trend
Net reducer
0 rate rises · 1 rate falls
Latest filing
19.08.2026
Active since 2017

Declared Swiss portfolio

Latest declared rate per company

Sector allocation

Share of companies held
How to read these figures?

Rates come from the 25 official filings published by SIX Exchange Regulation. A filing is only required when a threshold is crossed (3, 5, 10, 15, 20, 25, 33⅓, 50, 66⅔%): the actual position may have changed since.

Estimated value = shares held per the latest filing × latest CHF closing price. It is an indicative order of magnitude: the position may have changed without a new threshold being crossed, and holdings without a share count or a CHF price are not valued. Each company's mini-chart traces the successive declared rates.

This profile shows only what the declarant published. No external data is added to it.

Group structure

Shareholding disclosures are often filed jointly by several entities of the same group. The registry links them together: "Controls" lists the group entities declared alongside this shareholder, "Controlled by" the head entities. The figure is the number of joint disclosures, followed by the date of the most recent one.

Show group structure1 controls

Controls

Group entities linked to this shareholder in joint disclosures.

This mapping reflects observed disclosures; it does not necessarily indicate permanent legal control.

Disclosure behaviour

Upward and downward threshold crossings show direction, without measuring daily trades below legal thresholds.

90 days · Upward crossings

0

visible history: 2

90 days · Downward crossings

1

visible history: 23

First disclosure: 22.06.2017Last disclosure: 19.08.2026

Nature of disclosed positions

Derivatives, sale positions or lending may indicate a more complex strategy than a long equity holding.

Equity holdings
13
Rights / derivatives
19
Sale positions
302

Latest shareholding disclosures

Show 22 older disclosures
SaleShareholdings

Idorsia Ltd

Idorsia Ltd · Single shareholder

35.225%Voting rights sold22.10.2025
SaleShareholdings

Idorsia Ltd

Idorsia Ltd · Single shareholder

35.225%Voting rights sold16.10.2025
SaleShareholdings

Idorsia Ltd

Idorsia Ltd · Single shareholder

37.525%Voting rights sold04.10.2025
SaleShareholdings

Idorsia Ltd

Idorsia Ltd · Single shareholder

31.283%Voting rights sold29.08.2025
SaleShareholdings

Idorsia Ltd

Idorsia Ltd · Single shareholder

61.412%Voting rights sold28.08.2025
SaleShareholdings

Idorsia Ltd

Idorsia Ltd · Single shareholder

61.977%Voting rights sold27.05.2025
SaleShareholdings

Idorsia Ltd

Idorsia Ltd · Single shareholder

63.032%Voting rights sold19.03.2025
SaleShareholdings

Idorsia Ltd

Idorsia Ltd · Single shareholder

65.297%Voting rights sold18.03.2025
SaleShareholdings

Idorsia Ltd

Idorsia Ltd · Single shareholder

69.324%Voting rights sold12.03.2025
SaleShareholdings

Idorsia Ltd

Idorsia Ltd · Single shareholder

82.198%Voting rights sold04.03.2025
SaleShareholdings

Idorsia Ltd

Idorsia Ltd · Single shareholder

52.841%Voting rights sold05.09.2024
SaleShareholdings

Idorsia Ltd

Idorsia Ltd · Single shareholder

36.104%Voting rights sold23.03.2024
PurchaseShareholdings

Santhera Pharmaceuticals Holding AG

Idorsia Ltd · Single shareholder

12.99%Voting rights acquired04.03.2023
PurchaseShareholdings

Santhera Pharmaceuticals Holding AG

Idorsia Ltd · Single shareholder

22.13%Voting rights acquired13.01.2023
SaleShareholdings

Idorsia Ltd

Idorsia Ltd · Single shareholder

36.58%Voting rights sold13.01.2023
SaleShareholdings

Idorsia Ltd

Idorsia Ltd · Single shareholder

43.54%Voting rights sold30.07.2021
SaleShareholdings

Idorsia Ltd

Idorsia Ltd · Single shareholder

31.59%Voting rights sold28.10.2020
SaleShareholdings

Idorsia Ltd

Idorsia Ltd · Single shareholder

37.01%Voting rights sold08.10.2020
SaleShareholdings

Idorsia Ltd

Idorsia Ltd · Single shareholder

37.01%Voting rights sold07.10.2020
SaleShareholdings

Idorsia Ltd

Idorsia Ltd · Single shareholder

25.56%Voting rights sold08.03.2019
SaleShareholdings

Idorsia Ltd

Idorsia Ltd · Single shareholder

26.18%Voting rights sold05.07.2017
SaleShareholdings

Idorsia Ltd

Idorsia Ltd · Single shareholder

22.1%Voting rights sold22.06.2017

insider24.ch

Follow Idorsia Ltd’s disclosures

Find new disclosures in your watchlist. With Pro, receive email and Telegram alerts for your chosen companies.

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open

Management purchases in this portfolio

Loading activity…

    These figures aggregate public disclosures. They are not investment advice.

    Common questions

    Which Swiss companies are in Idorsia Ltd’s disclosed portfolio?

    Idorsia Ltd, Santhera Pharmaceuticals Holding AG.

    What is Idorsia Ltd’s latest disclosure?

    The latest available disclosure was published on 19.08.2026 and concerns Idorsia Ltd. Threshold disclosures do not describe every purchase or sale.

    Explore further

    Recent insider purchases

    What are insiders doing at companies disclosed by this shareholder?

    All purchases this week

    Insider barometer

    Compare insider purchases and sales across the Swiss stock exchange over 30 days.

    View the Swiss barometer

    These signals are not investment advice.